# Anthropic Accelerates Drug Development with Claude

> Anthropic partners with six biotech firms to use AI for faster drug discovery and clinical trials.
- Title: Anthropic Accelerates Drug Development with Claude · Anthropic
- Summary: Anthropic partners with six biotech firms to use AI for faster drug discovery and clinical trials. Anthropic's Claude AI helps six biotech companies develop…
- Keywords: anthropic, claude, drug development, biotech, clinical trials, molecular design, regulatory filings, rare diseases, cancer treatment, ai in medicine, technology, Accelerates
- Source: Anthropic — https://anthropic.com/research/early-progress-drug-development
- Published: 2026-10-27T00:00:00+00:00
- Read time: 1 min
- Topics: anthropic, claude, drug development, biotech, clinical trials, molecular design, regulatory filings, rare diseases, cancer treatment, ai in medicine, ai, technology
## Case studies
Anthropic’s life sciences team partners with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
## Drug development tasks
Developing a drug involves early research, molecule design, optimization, regulatory filings, clinical trials, and more.
## Claude's role
Anthropic uses Claude to support drug development across multiple disease areas and stages of development.
## Generate Biomedicines
Generate Biomedicines used Claude Code to shorten CAR T-cell therapy genetic instructions by 70%, creating more effective cancer treatments.
## Divergence Labs
Divergence Labs generated 35,000 antibody designs in a month using Claude to treat food allergies.
## BigHat Biosciences
BigHat Biosciences improved drug leads with Claude, increasing binding strength 10x and stability 18°C higher.
## Enveda
Enveda reduced human review time by 89% using Claude to flag issues in regulatory documents.
## The Column Group
The Column Group uses Claude to create Pleiades, a new company for more complex drug programs.
## Bristol Myers Squibb
Bristol Myers Squibb uses Claude to assess early-stage drug trial plans and success likelihood.
## Mithril Medicine
Mithril Medicine used Claude to advance rare muscular dystrophy treatments from idea to mouse results in 18 months.
## Next steps
Anthropic plans to expand Claude's role in clinical trials and share models with life science researchers.
## Claude Science
Anthropic launched Claude Science, an AI workbench for researchers, and provides credits for life scientists.
## Life Sciences Verification Program
Anthropic created a program to allow trusted organizations to use Claude with permissive safeguards.
## Future work
Anthropic aims to partner with more organizations to accelerate drug discovery using AI.
## Key takeaway

Anthropic's Claude AI helps six biotech companies develop new medicines faster, including treatments for rare diseases and cancer.